Evidence map›Paper›PMID 38352814›Full record

ArticleEuropean journal of case reports in internal medicine2024

'The Year of Living Dangerously': Successful

Miguel Franco-Álvarez, Iván Fernández-Castro, Mariño Francisco Fernández Cambeiro, Carmen Beceiro Abad, Esteban Otero Antón, Sandra Rodríguez López, María Dolores Calvo Barbeito, Ignacio Novo-Veleiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of case reports in internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Miguel Franco-ÁlvarezInternal Medicine Department, University Clinical Hospital, Santiago de Compostela, Spain.
Iván Fernández-CastroInternal Medicine Department, University Clinical Hospital, Santiago de Compostela, Spain.
Mariño Francisco Fernández CambeiroInternal Medicine Department, University Clinical Hospital, Santiago de Compostela, Spain.
Carmen Beceiro AbadHome Hospitalisation Unit, University Clinical Hospital, Santiago de Compostela, Spain.
Esteban Otero AntónInternal Medicine Department, University Clinical Hospital, Santiago de Compostela, Spain.
Sandra Rodríguez LópezHome Hospitalisation Unit, University Clinical Hospital, Santiago de Compostela, Spain.
María Dolores Calvo BarbeitoHome Hospitalisation Unit, University Clinical Hospital, Santiago de Compostela, Spain.
Ignacio Novo-VeleiroHome Hospitalisation Unit, University Clinical Hospital, Santiago de Compostela, Spain.
Complejo Hospitalario Universitario de Santiago · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case description: We present the case of a 71-year-old female liver transplant recipient. After being diagnosed with a mediastinal infection caused by Conclusions: The use of continuous vancomycin infusion has emerged as a safer, more efficient, and cost-effective alternative to intermittent administration. We want to emphasise the uniqueness of this case, where despite the unprecedented treatment duration, no adverse effects occurred. LEARNING POINTS: Vancomycin therapy based on continuous infusion represents a safer and cheaper strategy than classic intermittent administration.The use of continuous infusion facilitates the management of complex infections with outpatient antimicrobial therapy.

Indexed as

domiciliary antibiotic continuous infusionhome hospitalisationimmunocompromised patientRhodococcus equiVancomycin

Identifiers

PMID38352814
PMCPMC10860908
OpenAlexW4390788804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.